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Abstract
TechStep is a randomized trial of a mobile health interventions targeted towards transgender ado-
lescents. The interventions include a short message system, a mobile-optimized web application, and
electronic counseling. The primary outcomes are self-reported sexual risk behaviors and uptake of HIV
preventing medication. In order that we may evaluate the efficacy of several different combinations of
interventions, the trial has a sequentially randomized design. We use a causal framework to formalize
the estimands of the primary and key secondary analyses of the TechStep trial data. Targeted minimum
loss-based estimators of these quantities are described and studied in simulation.
1 Introduction
Transgender individuals are estimated to make up between 0.39% and 0.53% of the US population [7, 13],
with higher percentages of high school students identifying as transgender [8]. Transgender, gender non-
conforming, and gender non-binary (referred to here collectively as trans) demonstrate elevated rates of risky
sexual behaviors relative to their cisgender peers, leaving this population vulnerable to infection with human
immunodeficiency virus (HIV) [20]. A potential avenue for improvement in the health of trans youth is
through mobile technology-based interventions. Such interventions circumvent the face-to-face interaction
required for traditional health care delivery, and are therefore highly scalable. Moreover, technology-based
interventions may be extremely low cost, confidential, and can cultivate communication amongst users,
which may be important to trans youth who face high levels of stigma in healthcare and employment settings
[19, 17]. It is therefore of interest to design mobile interventions tailored to trans youth, and to evaluate the
efficacy of these interventions in preventing HIV infection.
The TechStep study is an ongoing randomized controlled trial (RCT) of mHealth interventions in high-
risk HIV-negative trans youths and young adults (15-24 years old). Three trans-specific mHealth interven-
tions were developed for TechStep: a short messaging service (SMS or text), a mobile-optimized webapp,
and an eCoaching intervention, which offers one-on-one risk behavior counseling administered through a
mobile video conferencing service [12, 30]. The goal of the trial is to evaluate the efficacy of these inter-
ventions for reducing sexual risk behaviors (e.g., condomless anal or vaginal intercourse, engagement in sex
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work, sex while feeling the effects of alcohol or drugs) and increasing uptake of pre-exposure prophylaxis
(PrEP).
The availability of multiple intervention modalities complicates the design of an RCT to evaluate its
efficacy. We must consider whether the mHealth interventions should be offered individually, all together,
or in a sequential fashion. A priori eCoaching might be expected to be the most effective intervention of the
three; however, from an implementation perspective, scalability may be limited due to its cost. These and
other considerations led to a sequential multi-arm randomized trial (SMART) design.
SMARTs randomize participants to an initial intervention and monitor participants after receipt of
the intervention [11, 14, 2, 15, 16, 6]. Based on interim data, participants may become eligible for re-
randomization to a new intervention. After receipt of the intervention, participants are monitored again.
Based on these new data (and all previous data), participants may again become eligible for re-randomization
to a new intervention. This process of monitoring and re-randomizing to different interventions continues
until a pre-specified timepoint. The data generated from such a trial can be used to evaluate the efficacy of
one or several treatment rules, that is, rules for how participants should be assigned treatment at each time.
SMART trials have great potential to advance HIV prevention science. Results of such trials can move
researchers closer to personalized care for individuals, and enable evaluation of interventions that are fea-
sible to implement. In this paper, we discuss the motivation for a SMART design in the TechStep trial, the
statistical methods needed to provide a robust and efficient analysis of the trial, and a simulation study to
assess the power of such the design to answer key questions of interest. We hope that this work will provide
researchers with a better understanding for the motivation of SMART HIV prevention trials, as well as some
ideas for how such trials can be planned and analyzed in practice.
2 Scientific questions and implications for design
The TechStep study is a planned RCT utilizing mHealth interventions in an HIV-negative trans adolescent
and young adult population (15 to 24 years of age). Three mHealth modalities for intervention were designed
for use in the trial: a text message system, a mobile-optimized webapp, and an eCoaching intervention. The
trial will have a total of nine months of follow-up with clinical assessments on participants taken at baseline
and at three-, six-, and nine months after enrollment. In this section, we define the primary and key secondary
questions for this study.
2.1 Primary question
To identify a primary question of interest, we define our outcomes and interventions of interest. For the
outcome, we focus on the cumulative number of risky sexual encounters, defined as acts of condomless anal
intercourse, engagement in sex work, or sex while feeling the effects of alcohol or drugs. We will consider
an intervention effective if it reduces the average number of risky encounters over the duration of the trial
or increases PrEP uptake.
Ideally, a primary analysis should assess an intervention that is feasible to implement in a broader clini-
cal setting [5]. We reasoned that many clinics could offer either a the text- or an webapp-based intervention,
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but not both. Moreover, such low intensity interventions may be sufficiently efficacious for many partici-
pants in reducing risky sexual behaviors. However, there may be individuals for whom the low intensity
interventions would be insufficient to change risk behaviors. These individuals may derive greater benefit
from the more intensive and personalized eCoaching intervention. For these reasons, TechStep considered
three interventions: (i) control intervention consisting of a static website with trans-specific HIV and risk re-
duction information and local and national trans resources, (ii) text + eCoaching, where participants receive
text messaging for ninety days and those who do not improve their risk behaviors receive three months of
eCoaching in addition to text messaging, and (iii) webapp + eCoaching, where participants receive access to
a webapp for ninety days and those who do not improve receive eCoaching for three months in addition to
the webapp. The primary goal of the trial is to compare average number of risky encounters for participants
who receive intervention (ii) vs. (i) and who receive intervention (iii) vs. (i).
2.2 Key secondary questions
Some health clinics may be unable to staff trained eCoaching counselors, and thus interventions (ii) and
(iii) may be infeasible to implement in some clinical settings. However, clinics could likely support ei-
ther a text message system or a webapp, since these interventions are extremely low cost. Therefore, we
wanted to evaluate the efficacy of two additional interventions: (iia) text messaging only, where participants
receive text messaging for six months and (iiia) webapp only, where participants receive access to a mobile-
optimized webapp for six months. A key secondary goal of the trial is to compare the average number of
risky encounters for participants who receive intervention (iia) vs. (i) and who receive intervention (iiia) vs.
(i).
While an eCoaching intervention is the most intensive and costly mHealth intervention we considered,
it is also hypothesized a-priori to be the most effective. Thus, it is also relevant to assess the marginal benefit
of offering eCoaching to participants whose behavior does not improve under other mHealth interventions.
To this end, another key secondary goal of the trial is to compare the average number of risk encounters for
participants who receive intervention (ii) vs. (iia) and (iii) vs. (iiia).
3 Causal Estimands
In this section, we introduce general notation to describe data collected in the TechStep trial, translate the
primary and secondary questions into formal causal estimands and establish their identifiability based on the
observed trial data. We use L0 = (Y0,W0) to denote a vector of baseline participant information collected at
the initial clinic visit. We use Y0 to denote sexual risk behaviors and W0 to denote other (e.g., demographic)
information collected. While in the actual TechStep trial, Y0 will consist of multiple measures of risk behav-
iors, for simplicity, here we consider that Y0 is scalar-valued. We use A0 to denote the intervention assigned
to participants at enrollment, with A0 = 0 denoting that standard of care was assigned, A0 = 1 denoting that
a first-line text intervention was assigned, and A0 = 2 denoting that a first-line webapp intervention was
assigned. We use C1 to denote whether a participant attends the three-month clinic visit, so that C1 = 0
denotes that the participant did not attend the visit, and C1 = 1 denotes that the participant did attend the
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visit. For participants who attend the three-month visit, we measure additional information on sexual risk
behaviors over the last three months. In particular, L1 = (Y1,W1) denotes a vector of participant information
collected at the three-month visit, where, as above, we use Y1 to denote sexual risk behaviors over the first
three months of the study, and W1 denotes other information collected on participants. We use A1 to denote
the intervention assigned to participants at the three-month visit. For simplicity, here we consider that par-
ticipants with Y1 ≥Y0 and Y1 6= 0, i.e., those who have at least some risky behaviors and whose behaviors do
not improve under the first-line intervention, are re-randomized to either maintain their current intervention
or to “step-up” to eCoaching. We set A1 = 3 if a participant is chosen to step-up and set A1 = A0 otherwise.
Participants who have no risky behaviors or whose behaviors have improved under first-line intervention
maintain their current intervention, A1 = A0.
We use C2 to denote whether a participant attends the six month clinic visit and L2 = (Y2,W2) to denote
information collected at this visit. Similarly, we define C3 and Y3 for the nine month clinic visit. We denote
by Y =Y1+Y2+Y3 the cumulative outcome over the duration of the study. Thus, the time-ordered data for a
typical study participant can be represented as a random variable O=(L0,A0,C1,L1,Y1,A1,C2,L2,Y2,C3,Y3).
We denote by P the distribution of the observed data unit O and assume a nonparametric model for P.
To define our causal question of interest, we use a nonparametric structural equation model (NPSEM).
This model assumes that each observed variable is a function of its parent variables and an exogenous
error term. We adopt a model that assumes the parents of a given observed variable are all variables that
temporally precede it. For example, L0 has no parent variables, the parent of A0 is L0, the parent of C1 is A0
and L0, and so on. We define interventions on this NPSEM that correspond to interventions (i), (ii), (iia),
(iii), and (iiia) above. In addition to intervening on the mHealth variables (A0 and A1), these interventions
enforce that participants attend each clinic visit. We define a function d that maps A0,Y0,Y1 to {0,1,2,3},
and defines our rules for stepping people up to the eCoaching intervention,
d(a0,y0,y1) =

0 if a0 = 0
1 if a0 = 1 and (y1 < y0 or y1 = 0)
2 if a0 = 2 and (y1 < y0 or y1 = 0)
3 if a0 6= 0 and y1 ≥ y0 and y1 6= 0
The interventions of interest are shown in Table 1. We denote by Y (i), Y (ii), Y (iia), Y (iii), Y (iiia) the coun-
terfactual outcomes generated by interventions (i), (ii), (iia), (iii), and (iiia), respectively. For example, Y (i)j
represents the total number of reported risky sexual behaviors over the duration of the trial, if, possibly
counter to fact, individual j received standard of care throughout the trial. We use Y (·) to generically denote
one of these counterfactual outcomes. The distribution of the counterfactual variable Y (·) is denoted by P(·).
We are interested in ψ (·) =E(Y (·)) =
∫
ydP(·)(y) for each intervention. Our primary and secondary questions
can be answered using statistical inference about parameters of the counterfactual outcome distributions. In
particular, we quantify intervention effects in terms of additive differences in the average number of mean
outcome over the duration of the trial. The causal estimands of interest pertaining to each of our primary
and secondary questions are shown in Table 2.
In this section, we discuss identification of E(Y (ii)) using P, the distribution of the observed data. Nearly
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Label NPSEM intervention Description
(i) A0 = 0,C1 = 1,A1 = 0,C2 = 1,C3 = 1
standard of care for 6 months
and attend each visit
A0 = 1,C1 = 1 text messages for 3 months, step up
(ii) A1 = d(1,Y0,Y1) to eCoaching if no improvement at 6
C2 = 1,C3 = 1 months and attend each visit
(iia) A0 = 1,C1 = 1,A1 = 1, C2 = 1,C3 = 1
text messages for 6 months
and attend each clinic visit
A0 = 2,C1 = 1 webapp for 3 months, step up
(iii) A1 = d(2,Y0,Y1) to eCoaching if no improvement at 6
C2 = 1,C3 = 1 months and attend each visit
(iiia) A0 = 2,C1 = 1,A1 = 2, C2 = 1,C3 = 1
webapp for 6 months
and attend each clinic visit
Table 1: Hypothetical interventions on nonparametric structural equation model.
Question Causal estimand Description
Primary
E(Y (ii))−E(Y (i)) difference in mean outcome under text
+ step intervention versus standard of care
E(Y (iii))−E(Y (i)) difference in mean outcome under webapp
+ step intervention versus standard of care
Secondary
E(Y (iia))−E(Y (i)) difference in mean outcome under text-only
versus standard of care
E(Y (iiia))−E(Y (i)) difference in mean outcome under webapp-only
versus standard of care
E(Y (ii))−E(Y (iia)) difference in mean outcome under text
+ step versus text only
E(Y (iii))−E(Y (iiia)) difference in mean outcome under webapp
+ step intervention versus webapp only
Table 2: Causal estimands used to answer primary and secondary questions of interest.
5
identical arguments can be used to establish identifiability of the other causal estimands. We use the lon-
gitudinal G-formula to establish identifiability; see [21, 1, 10] for more on the assumptions under which
this identification result holds. We draw particular attention to the assumption of sequential randomiza-
tion of intervention and missingness, also referred to as the assumption of no unmeasured (time-varying)
confounding. The SMART design of the trial ensures that intervention rules are randomly assigned and
thus that observed intervention values are independent of counterfactual outcomes. However, as with any
clinical trial, we expect that participants will miss clinic visits. Thus, in order that the sequential random-
ization assumption is satisfied, we require that amongst those participants who receive intervention (ii), Ct
is independent of Y (ii) given L¯t−1, the covariate information collected up to time t−1. That is, the covariate
history L¯t−1 should include all individual characteristics that are related both to participants’ propensity for
risky sexual behaviors and for attending future clinic visits. We will adopt this bar notation throughout to
denote a collection past measurements of particular variables. For example, C¯t = (C1, . . . ,Ct) for t = 1,2,3.
We will sometimes write 1¯ to denote a unit vector, the length of which will be apparent from the context.
For example, C¯3 = 1¯ denotes the event that C1 = 1,C2 = 1,C3 = 1, while C¯2 = 1¯ denotes the event that
C1 = 1,C2 = 1, and so on.
If the assumptions described above are satisfied, then E(Y (ii)) can be written as a functional of P, for
which we require the following definitions. We define Q3(y, ¯`2) as the conditional CDF of Y given A0 =
1,A1 = h(1,y0,y1),C¯3 = 1¯, and L¯2 = ¯`2 evaluated at y. In words, Q3(y, ¯`2) describes the probability of having
fewer than or equal to y risky sexual encounters over the duration of the trial, amongst the participants in
intervention arm (ii) that attended each of the three follow-up visits and had observed covariate history
¯`2. Similarly, we define Q2( ¯`2) as the conditional CDF of L2 given A0 = 1,A1 = h(1,y0,y1),C¯2 = 1¯, L¯1 = ¯`1
evaluated at `2, and we define Q1( ¯`1) as the conditional CDF of L1 given A0 = 1,C1 = 1, and L0 = `0. Finally,
we define Q0(`0) as the conditional CDF of L0 evaluated at `0. The G-formula for the causal estimand of
interest is
E(Y (ii)) =
∫
Q¯1(`0)dQ0(`0) ,
where Q¯1 is recursively defined as follows,
Q¯1(`0) =
∫
Q¯2( ¯`1) dQ1( ¯`1) (1)
Q¯2( ¯`1) =
∫
Q¯3( ¯`2) dQ2( ¯`2) (2)
Q¯3( ¯`2) =
∫
y dQ3(y, ¯`2) . (3)
4 Statistical Methodology
Well-controlled randomized trials generally allow researchers to utilize covariate-unadjusted statistical meth-
ods to draw inference on causal effects, since, by virtue of the randomized design, counterfactual outcomes
are marginally independent of intervention assignment. However, the same is not true in SMART trials, as
sequential randomization probabilities depend on past covariates. Thus, these covariates must be accounted
for by the estimator in order to draw valid inference. A more challenging issue is that typically at least some
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follow-up data are missing in randomized trials, for example, due to participants moving out of the study
region. Simple strategies, such as complete-case analysis, run the risk of incurring bias due to informative
missingness. To draw more robust inference, we can utilize estimators that account for all measured covari-
ates, not just those that are used to determine re-randomization probabilities. If the measured covariates are
rich enough to satisfy the sequential randomization assumption on missingness, then we should be able to
draw valid inference about intervention effects, in spite of the informative nature of the missingness.
We will analyze the TechStep trial using targeted minimum loss-based estimation (TMLE) [27, 25, 26].
TMLE is a general framework for generating plug-in estimators that solve a set of user-selected equations
[23]. In the present problem, we sequentially generate estimates of the parameters of the G-formula (1)-(3)
that solve the efficient influence function estimating equation. We refer interested readers to [18, 22] for
technical derivations of the underpinnings of TMLE in the present context.
From a high level, our estimator is built in several stages. In the first stage (Section 4.1), we obtain
estimates of randomization probabilities and the probability of a participant attending each clinic visit. Col-
lectively, we refer to these probabilities as the propensity scores. These propensity scores, in particular, the
components pertaining to missingness probabilities are used in the procedure to control for the possibility
of time-varying confounding based on measured participant characteristics.
With estimates of the propensity scores in hand, we proceed to estimating the outcome process using a
sequence of regressions and starting at the final timepoint. Each of these outcome regressions involves two
steps: obtaining an initial regression estimate and augmenting this estimate using fluctuation submodels.
The purpose of the first step is to obtain an estimator that adjusts for potential time-varying confounders of
the outcome and missingness process. The purpose of the second step is to ensure that the efficient influence
function estimating equation is satisfied, which in turn endows the TMLE with desirable robustness and
efficiency properties. Notably, the TMLE controls for potential time-varying confounding in two ways –
through estimation of propensity scores and through sequential estimation of the outcome process. The
augmentation step is the crucial step in wedding these two approaches. In particular, this step ensures that,
so long as either the outcome process or the propensity scores are consistently estimated, the resultant TMLE
is consistent. That is, it ensures the estimator is doubly robust. For more on double-robustness in the present
context, see [1, 10].
To provide a concrete example, below we consider that W0,W1, and W2 are scalar-valued.
4.1 Estimating propensity scores
Our first task is to estimate the randomization probabilities for the text + step-to-eCoaching intervention.
Specifically, we require estimates of
g¯A,0 = P(A0 = 1) and
g¯A,1(y0,y1) = P(A1 = d(1,Y0,Y1) | A0 = 1,C1 = 1,L0 = `0,Y1 = y1) .
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While these probabilities are known by design, our estimators will utilize empirical estimates to account for
chance imbalances between intervention arms. To that end, we define
g¯A,0n =
1
n
n
∑
i=1
1(A0i = 1) and
g¯A,1n(y0,y1) =
{
∑ni=11(A0i=1, C1i=1, A1i=3)
∑ni=11(A0i=1, C1i=1)
y1 ≥ y0 and y1 6= 0
1 else
.
Note that the latter estimator accounts for our step-up criteria. If a participant’s sexual risk behaviors do not
improve, then they are eligible for step up and may be re-randomized to the eCoaching intervention. We
estimate this re-randomization probability using an empirical proportion. If, on the other hand, a partici-
pant’s sexual risk behaviors improve, then that participant is not eligible for step up and stays on the text
intervention with probability 1.
The second step is to estimate the probability of missing each clinic visit as a function of past covariates.
In particular, for each covariate history ¯`2, we require an estimate of
g¯C,1(`0) = P(C1 = 1 | A0 = 1,L0 = `0) ,
g¯C,2( ¯`1) = P(C2 = 1 | A0 = 1,C1 = 1,A1 = d(1,y0,y1), L¯1 = ¯`1) , and
g¯C,3( ¯`2) = P(C3 = 1 | A0 = 1,C1 = 1,A1 = d(1,y0,y1),C2 = 1, L¯2 = ¯`2) .
These estimates can be obtained, for example, using logistic regression. Considering estimation of g¯C,1,
we could posit a logistic regression model, and regress the binary outcome C1 onto basis functions of L0
amongst participants randomized to the text intervention. Alternatively, we could posit a logistic regression
model for the probability of attending the first clinic visit as a function of A0 and L0, and regress C1 onto
basis functions of L0 and A0 amongst all participants. As a concrete example, consider the main-terms
logistic regression model for g˜C,1(a0, `0) = P(C1 = 1 | A0 = a0,L0 = `0),
logit{g˜C,1(a0, `0)}= γ0+ γ11(a0 = 1)+ γ21(a0 = 2)+ `0γL , γ ∈ R5 ,
where γ = (γ0,γ1,γ2,γL)> and γL is a two-dimensional vector of parameters associated with W0 and Y0. We
note that this regression pools across interventions to estimate the conditional probability of attending the
first clinic visit. An estimate γˆ of γ can be obtained via maximum likelihood. We use g˜C,1n(a0, `0) to denote
the fitted value from this regression for an observation with A0 = a0 and L0 = `0. For any `0 our estimate of
g¯C,1 is
g¯C,1n(`0) = g˜C,1n(1, `0) = logit−1(γˆ0+ γˆ1+ `0γˆL) .
To estimate g¯C,2 we take a similar approach. For example, we could posit a logistic regression model for the
probability of attending the second clinic visit as a function of A¯1 and L¯1, and regress C2 onto basis functions
of A¯1 and L¯1 using data from all participants who attended the first clinic visit. As a concrete example,
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consider the main-terms logistic regression model for g˜C,2(a0,a1, ¯`1) = P(C2 = 1 | A0 = a0,C1 = 1, L¯1 = ¯`1),
logit{g˜C,2(a0,a1, ¯`1)}= η0+η11(a0 = 1,a1 = 1)+η21(a0 = 2,a1 = 2)
+η31(a0 = 1,a1 = 3)+η41(a0 = 2,a1 = 3)+ ¯`1ηL ,
η ∈ R9 ,
where η = (η0,η1, . . . ,η4,ηL) and ηL is a four-length vector of regression parameters associated with
Y0,W0,Y1, and W1. An estimate ηˆ of η can be obtained via maximum likelihood, and similarly as above, we
use g¯C,2n(a0,a1, ¯`1) to denote the fitted value from this regression for an observation with A0 = a0, A1 = a1,
and L¯1 = ¯`1. For any ¯`1 our estimate of g¯C,2 is
g¯C,2n( ¯`1) = g˜C,2n(1,d(1,y0,y1), ¯`1)
= logit−1
{
ηˆ0+ ηˆ11(d(1,y0,y1) = 1)+ ηˆ31(d(1,y0,y1) = 3)+ ¯`1ηˆL
}
.
Finally, we estimate the conditional probability of attending the third clinic visit similarly as with the second
to obtain g¯C,3n, an estimate of g¯C,3.
4.2 Estimating sequential outcome regressions
We now turn to obtaining an estimate of Q¯3, the conditional mean of the cumulative number of risky sexual
behaviors amongst participants in the text + step-to-eCoaching who attended each clinic visit given their
sexual risk behaviors and covariates measured through the second clinic visit. We can write (3) as
Q¯3( ¯`2) = E(Y | A0 = 1,A1 = d(1,y0,y1),C¯3 = 1¯, L¯2 = ¯`2)
= y1+ y2+E(Y3 | A0 = 1,A1 = d(1,y0,y1),C¯3 = 1¯, L¯2 = ¯`2)
≡ y1+ y2+ Q˜3(1,d(1,y0,y1), ¯`2) ,
where we defined Q˜3(a0,a1, ¯`2) = E(Y3 | A0 = a0,A1 = a1,C¯3 = 1¯, L¯2 = ¯`2). The second equality follows
from the fact that we are conditioning on L¯2 = ¯`2, which includes past sexual risk behaviors y1 and y2.
Thus, in order to estimate Q¯3, it suffices to estimate Q˜3. For example, since Y3 is a count variable, we
could posit a generalized linear model with Poisson family and log link function for Q˜3. As with estimation
of missingness probabilities, we will use regressions that pool over intervention groups, by regressing the
outcome Y3 onto basis functions of A¯2 and L¯2. To provide a concrete example, we consider the following
pooled, log-linear regression model for Q˜3,
log{Q˜3(a0,a1, ¯`2)}= β0+β11(a0 = 1,a1 = 1)+β21(a0 = 2,a1 = 2)
+β31(a0 = 1,a1 = 3)+β41(a0 = 2,a1 = 3)+ ¯`2βL ,
β ∈ R12 .
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An estimate βˆ of β can be obtained via maximum likelihood, and we denote by Q˜3n(a0,a1, ¯`2) the fitted
value from this regression for an observation with A¯1 = a¯1 and L¯2 = ¯`2. For any ¯`2 an estimate of Q¯3( ¯`2) is
Q¯3n( ¯`2) = y1+ y2+ Q˜3n(1,d(1,y0,y1), ¯`2) (4)
= y1+ y2+ exp
{
βˆ0+ βˆ11(d(1,y0,y1) = 1)
+ βˆ31(d(1,y0,y1) = 3)+ ¯`2βˆL } .
Next, we augment our initial estimate of Q˜3 by estimating the parameter of a fluctuation submodel
associated with the augmentation covariate
H3n(a0,a1, c¯3, ¯`2) =
1(a0 = 1,a1 = d(1,y0,y1), c¯3 = 1¯)
g¯A,0n g¯A,1n(y0,y1) ∏3t=1 g¯C,tn( ¯`t−1)
.
Recall, that TMLE is a general purpose tool for generating estimators that solve user-specified equations. In
the current problem, we need an estimate Q¯∗3n of Q¯3 that satisfies
1
n
n
∑
i=1
H3n(A0i,A1i,C¯3i, L¯2i){Y − Q¯∗3n(L¯2i)}= 0 . (5)
This can be achieved as follows. First, we compute maximum observed value of Y3, denoted by s3[n] and we
scale Y3 to the unit interval, Y s3 = Y3/s3[n]. Next, we define the augmented regression model,
logit
{
Q˜3(a0,a1, ¯`2)/s3[n]
}
= logit{Q˜s3n(a0,a1, ¯`2)/s3[n]}+ ε3H3n(a0,a1, c¯3, ¯`2) , ε3 ∈ R .
Estimating the parameter ε3 corresponds to fitting a logistic regression in subset of participants C¯2 = 1¯,
where the outcome is Y s3 , the regressor is H3n, and the model includes an offset equal to the logit of the
scaled fitted value. Denoting by ε3n the estimate of ε3, the augmented estimate of Q˜3 is
Q˜∗3n(a0,a1, ¯`2) = s3[n]logit
−1 [logit{Q˜3n( ¯`2)/s3[n]}+ ε3nH3n(a0,a1, 1¯, ¯`2)] .
Thus, for a given ¯`2, the augmented estimate of Q¯3( ¯`2) is
Q¯∗3n( ¯`2) = y1+ y2+ Q˜
∗
3n(1,d(1,y0,y1), ¯`2) .
It is straightforward to show that Q¯∗3n satisfies equation (5), as required.
Our next task it to obtain an estimate of Q¯2, the conditional mean of Q¯3 amongst participants in the
text + step-to-eCoaching intervention who attended clinic visits one and two, and given covariate-history
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measured through the first follow-up clinic visit. We can write (2) as
Q¯2( ¯`1) = E{Q¯2(L¯2) | A0 = 1,A1 = d(1,y0,y1),C¯2 = 1¯, L¯1 = ¯`1}
= y1+E{Y2+ Q˜3(A0,A1, L¯2) | A0 = 1,A1 = d(1,y0,y1),C¯2 = 1¯, L¯1 = ¯`1}
≡ y1+ Q˜2(1,d(1,y0,y1), ¯`1) ,
where we defined Q˜2(a0,a1, ¯`1) = E{Q˜3(A0,A1, L¯2) | A0 = a0,A1 = a1,C¯2 = 1¯, L¯1 = ¯`1}. Thus, to estimate
Q¯2, it suffices to estimate Q˜2. This quantity could be estimated, as above, using a pooled log-linear regression
model,
log{Q˜2(a0,a1, ¯`1)}= ν0+ν11(a0 = 1,a1 = 1)+ν21(a0 = 2,a1 = 2)
+ν31(a0 = 1,a1 = 3)+ν41(a0 = 2,a1 = 3)+ ¯`>1 νL , ν ∈ R9 .
In order to appropriately pool over the intervention groups, we estimate the parameters of this regression us-
ing a stacked data set with five rows for each original observation, for a total of 5n rows. We evaluate the fit-
ted value Q˜∗3n(a0,a1, L¯1i) and set the stacked outcome Y2i+Q˜(a0,a1, L¯1i) for (a0,a1)∈{(1,d(1,Y0i,Y1i)),(2,d(2,Y0i,Y1i)),(1,1),(2,2),(0,0)}.
Thus, the first n rows of the stacked data set correspond to fitted values with interventions set to (1,d(1,Y0,Y1)),
the second n rows correspond to fitted values with interventions set to (2,d(2,Y0,Y1)), and so on. Accord-
ingly, the first n entries in the stacked A0 column equal to 1, the next n equal to 2, the next n equal to 1,
the next n equal to 2, the final n equal to 0. Similarly, the first n entries in the stacked A1 column equal to
d(1,Y0i,Y1i), i= 1, . . . ,n, the next to d(2,Y0i,Y1i), i= 1, . . . ,n, and so on. All previously measured covariates,
(W0,Y0,W1,Y1), are copied five times to complete the stacked data set.
An estimate νˆ of ν can be obtained by fitting the log-linear regression model above to the subset of the
stacked data with C¯2 = 1¯. We denote by Q˜2n(a0,a1, ¯`2) the fitted value from this regression for an observation
with A¯1 = a¯1 and L¯1 = ¯`1. Thus, our estimate of Q¯2 is
Q¯2n( ¯`1) = y1+ Q˜2n(1,d(1,y0,y1), ¯`1)
= y1+ exp
{
νˆ0+ νˆ11(d(1,y0,y1) = 1)+ νˆ31(d(1,y0,y1) = 3)+ ¯`1νˆL
}
.
As above, the next step is to augment the initial estimate of Q˜2 using an appropriate fluctuation submodel.
To that end, we define the augmentation covariate
H2n(a0,a1, c¯2, ¯`1) =
1(a0 = 1,a1 = d(1,y0,y1), c¯2 = 1¯)
g¯A,0n g¯A,1n(y0,y1) ∏2t=1 g¯C,tn( ¯`t−1)
.
The goal of this augmentation step is to generate an estimate Q¯∗2n of Q¯2 that satisfies
1
n
n
∑
i=1
H2n(A0i,A1i,C¯2i, L¯2i){Q¯∗3n(L¯2i)− Q¯∗2n(L¯1i)}= 0 . (6)
This can be achieved using a similar strategy as above. First, we compute the maximum observed value of
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Y2+Q˜∗3n(1,d(1,Y0,Y1), L¯2), say s2n. We then generate a scaled outcome Y
s
2 = {Y2+Q˜3n(1,d(1,Y0,Y1), L¯2)}/s2n.
Next, we define an augmented regression model for Q˜2,
logit
{
Q˜2(a0,a1, ¯`1)/s2n
}
= logit{Q˜2n(a0,a1, ¯`1)/s2n}+ ε2H2n(a0,a1, c¯2, ¯`1) , ε2 ∈ R .
Estimating the parameter ε2 corresponds with fitting a logistic regression in the subset of participants with
C¯2 = 1¯, where the regression outcome is Y s2 , the single covariate is H2n, and the model includes an offset
equal to the logit of the scaled fitted value. Denoting by ε2n the estimate of ε2, the augmented estimate of
Q˜2 is
Q˜∗2n(a0,a1, ¯`1) = s2nlogit
−1 [logit{Q˜2n(a0,a1, ¯`1)/s2n}+ ε2nH2n(a0,a1, c¯2, ¯`1)] .
Thus, the augmented estimate of Q¯2( ¯`1) is Q¯∗2n( ¯`1) = y1 + Q˜
∗
2n(1,d(1,y0,y1), ¯`1). It is straightforward to
show that Q¯∗3n and Q¯
∗
2n together satisfy equation (6).
Our next task it to obtain an estimate of Q¯1, the baseline-covariate-conditional mean of Q¯2 amongst
participants initially in the text intervention who attended clinic visit one. We can write (1) as
Q¯1(`0) = E{Q¯2(L¯1) | A0 = 1,C1 = 1,L0 = `0}
= E{Y1+ Q˜2(1,d(1,Y0,Y1), L¯1) | A0 = 1,C1 = 1,L0 = `0}
≡ Q˜1(1, `0) ,
where we defined Q˜1(a0, `0) =E{Y1+Q˜2(1,d(1,Y0,Y1), L¯1) |A0 = a0,C1 = 1,L0 = `0}. Obtaining an initial,
and subsequently, an augmented estimate of Q¯1 proceeds similarly as with Q¯2. We first obtain an initial
estimate of Q˜1, e.g., through log-linear regression on a stacked data set. To generate this stacked data set,
we evaluate the fitted value Q˜∗2n(a0,a1, L¯1i) and define the stacked outcome Y1i+ Q˜2(a0,a1, L¯1i) for
(a0,a1) ∈ {(1,d(1,Y0i,Y1i)),(2,d(2,Y0i,Y1i)),(1,1),(2,2),(0,0)} .
Next, we make a stacked column of baseline intervention assignments, with the first n observations equal
to 1, the next n equal to 2, the next n equal to 1, the next n equal to 2, the final n equal to 0. All baseline
covariates, (W0,Y0), are copied five times to complete the stacked data set. Then, as above, we fit our
regression on the stacked data set, regressing the stacked outcome on the stacked baseline intervention and
covariates. Given `0, our estimate of Q¯1(`0) is Q¯1n(`0) = Q¯1n(1, `0).
We augment Q¯1n using the covariate
H1n(a0,c1, `0) =
1(a0 = 1,c1 = 1)
g¯A,0n g¯C,1n(`0)
,
with the goal generating an estimate Q¯∗1n of Q¯1 that satisfies
1
n
n
∑
i=1
H1n(A0i,C1i,L0i){Q¯∗2n(L¯1i)− Q¯∗1n(L¯0i)}= 0 . (7)
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We again use logistic regression to this end. The scaled outcome is Y s1 = {Y1+ Q˜2n(1,d(1,Y0,Y1), L¯2)}/s1n,
where s1n is the maximum observed value of Y1+ Q˜2n(1,d(1,Y0i,Y1i), L¯1i). As in previous steps, we regress
the scaled outcome Y s1 onto the covariate H1n with offset equal to logit(Q¯1n/s1n).
Denoting by ε1n the estimate of ε1, the augmented estimate of Q¯1(`0) is
Q¯∗1n(`0) = s1nlogit
−1 [logit{Q¯1n(`0)/s1n}+ ε1nH1n(1,1, `0)] .
It is straightforward to show that Q¯∗2n and Q¯
∗
1n together satisfy equation (6).
The final step is to plug-in the estimate Q¯∗1n into right-hand-side of equation (3). To evaluate this plug in
estimator, we also need an estimate of Q0, the cumulative distribution of L0. For this, we use the empirical
distribution Qn(`0) = 1n ∑
n
i=11(L0i ≤ `0). The final TMLE estimator is thus
ψ∗n =
∫
Q¯∗1n(`0)dQn(`0) =
1
n
n
∑
i=1
Q¯∗1n(L0i) .
It is straightforward to obtain closed-form, Wald-style confidence intervals and hypothesis tests based on
TMLE-estimated treatment effects using the calculus of influence functions and the functional delta method
[28]. We provide more information on these methods in the Appendix.
4.3 Note on propensity score and outcome regression estimators
In the above description of TMLE, we used initial estimators based on parametric models to illustrate key
ideas. However, TMLE methodology is in no way limited to such estimators. In particular, we may wish to
consider more flexible regression techniques in order to mitigate the risk of residual bias incurred by regres-
sion model misspecification. To that end, it may be propitious to utilize super learning [24], a generalization
of regression stacking [29, 4]. A super learner can build estimators of regression quantities by considering
all possible convex combinations of a library of pre-specified regression estimators. That is to say, a fitted
value from a super learner regression is a weighted combination of fitted values from various candidate re-
gression estimators. The candidate regression estimators can range from parametric regression estimators to
highly data-adaptive estimators. The super learner selects weights assigned to each candidate estimator by
finding the convex weights that minimize a cross-validated risk criteria, for example, cross-validated mean
squared-error. The use of super learner is particularly appealing in the context of randomized trials in that
the method can be fully pre-specified and is essentially a nonparametric method so long as sufficiently flex-
ible regressions are included in the library. For these reasons, in the analysis of the TechStep trial, we will
use the super learner to estimate the conditional probabilities of missingness and the sequential outcome
regressions described in the previous paragraph.
5 Simulation
We performed extensive simulations to determine the sample size required to detect clinically meaningful
differences in average risk behaviors in the TechStep trial. For simplicity, we assumed W0 was scalar-
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Parameter Values Notes
n 200, 250, 300 Sample size
γ1 0, -0.11, -0.22, -0.36 Text eff. on risky behaviors
γ2 0, -0.22, -0.51 Webapp eff. on risky behaviors
γ3
0, -0.11, -0.22, -0.36,
ECoaching eff. on risky behaviors
-0.69∗, -0.92∗, -1.20∗, -1.61∗
α0 -4.06, -3.35 Loss-to-followup of 5% and 10%
Table 3: Simulation parameter values and descriptions. Values of γi are log rate ratios. ∗ denotes that
simulations were performed only when γ1 = 0,−0.11.
valued and drawn from a Bernoulli(1/2) distribution. Baseline sexual risk behaviors Y0 were drawn from a
Poisson(exp(γ0)) distribution, where γ0 is the log-average number of risk behaviors. Using estimates from
published data [9, 20], we set γ0 = log(1.5). The treatment A0 was assigned randomly with 1/3 proba-
bility of control, text-, and webapp-based interventions. Data for the 3, 6, and 9-month visits were gen-
erated as follows. For t = 1,2,3, we drew Ct from Bernoulli(logit−1(α0)) distribution; thus, α0 controls
the level of participant dropout. Given Ct = 1 (i.e., that the participant attended clinic visit t), we drew
Yt from a Poisson distribution with conditional mean (Yt−1∨ 15)exp{γA,11(A(t−1)∧1 = 1)+ γA,21(A(t−1)∧1 =
2)+ γA,31(A(t−1)∧1 = 3)+ γWW0}. Here, x1∨x2 and x1∧x2 denote the smaller and larger of two real-valued
numbers x1,x2, respectively. Note that this corresponds to a Markov model, where the only factors of partic-
ipants’ history that influence their risk behaviors are their most recently measured risk behaviors (Yt−1), their
most recent treatment (A(t−1)∧1), and baseline covariate W0. We consider a wide range of scenarios by se-
lecting different values of simulation parameters (Table 3). For each combination of simulation parameters,
we analyzed five hundred data sets. Power for each choice of n and for each of the comparisons shown in
Table 2 was estimated by the proportion of simulations in which the two-sided level 0.05 Wald test rejected
the null hypothesis of no difference in average number of risky behaviors. To estimate the conditional prob-
ability of censoring, we used main terms logistic regression. To estimate the sequential outcome regression,
we used the super learner based on five-fold cross-validation with a library of candidate regressions that
consisted of an intercept-only model, a Poisson regression model, a negative binomial regression model,
and the highly adaptive LASSO [3]. The latter is a flexible semiparametric regression estimator.
For the primary analysis, we found that type I error rate was adequately controlled for each sample size
considered (Figure 1). Across a wide range of settings, we estimated that we have 80% power to detect a
difference in 1.60 average risk behaviors comparing text+step versus control at n = 300, 1.75 at n = 250,
and 1.90 at n = 200. These results seem to be robust across situations where the majority of the benefit is
derived from the text versus from the eCoaching component of the intervention. Increasing censoring from
5% to 10% (left versus right column of Figure 1) tended to decrease power by 3-5%. For the secondary
analysis examining the effect of text+step versus text-only interventions we found that type I error rates
were slightly higher than the nominal level in the smallest sample size (Figure 2). We found similar power
curves for this secondary analysis as with the primary analysis. There tended to be higher power to detect
differences when there was a small effect of the text intervention (γ1 = −0.11) relative to no effect of the
text intervention (γ1 = 0). Results for the simulation studying the secondary analysis that compares efficacy
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of text-only versus app-only are included in the supplementary material. These results were similar to the
primary analysis with 80% power to detect differences in average number of risk behaviors of between 1.60
and 1.90. Results for comparing text-only versus app-only interventions are shown in Figure 3. We found
a minor increase in type I error for this comparison using the proposed test. Across the various settings,
there is 80% power to detect an average difference of about two risk behaviors between the text-only and
app-only interventions.
6 Discussion
Based on these simulation results and other criteria, a target of n = 250 was set for enrollment in the Tech-
Step trial. Our simulation results suggest this sample size will afford sufficient power to detect clinically
meaningful differences between interventions, and balances power appropriately between the primary anal-
yses and key secondary analyses.
Further research is warranted in several areas. First, our Wald tests were slightly anti-conservative for
testing differences between the text+step versus text condition. We will explore alternative standard er-
ror estimators including cross-validated influence function-based standard errors. Second, we may wish to
evaluate whether and how to adjust for intervention engagement (e.g., webapp paradata) in the primary and
secondary analyses. If such information is predictive of risky behaviors, then incorporating such information
may lead to improved power to detect differences amongst the interventions. Finally, we will explore dif-
ferent techniques for time-varying confounder selection. Extensive surveys will be collected at each clinic
visit, so W0,W1,W2 are all potentially high-dimensional vectors. We will evaluate different strategies for
selecting components to include in the primary and secondary analyses.
Appendix
Confidence intervals and hypothesis tests based on influence functions
We note that our specific labeling of interventions (e.g., A0 = 1 correpsonds to text, A0 = 2 to app, etc...) is
arbitrary. Moreover, by redefining the rule d(a0,y0,y1) (e.g., to equal a constant for any value of a0), then
we can directly apply the methodology described in the main text to estimate the counterfactual outcome
under any of the interventions of interest. Let ψ(·)n denote the TMLE of E[Y (·)]. Similarly, let Q¯(·)tn denote
the augmented sequential outcome regression estimate and H(·)tn the augmentation covariate. Define the
estimated influence function of ψ(·)n evaluated on observation i as ∑3t=0 D
(·)
ti , where
D(·)3i = H
(·)
3n (A0i,A1i,C¯3i, L¯2i){Y − Q¯(·)3n(L¯2i)}
D(·)2i = H
(·)
2n (A0i,A1i,C¯2i, L¯1i){Q¯(·)3n(L¯2i)− Q¯(·)2n(L¯1i)}
D(·)1i = H
(·)
1n (A0i,C1i,L0i){Q¯(·)2n(L¯1i)− Q¯(·)1n(L0i)}
D(·)0i = Q¯
(·)
1n(L0i)−
∫
Q¯(·)1n(`0)dQn(`0) .
15
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.
0
0.
4
0.
8
γ1 = 0
Po
w
e
r 
o
f t
wo
−
si
de
d 
te
st
l l
l
l
l
l
l
l l
l
n
200
250
300
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.
0
0.
4
0.
8
γ1 = −0.11
Po
w
e
r 
o
f t
wo
−
si
de
d 
te
st
l
l
l
l
l
l
l
l l
l
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.
0
0.
4
0.
8
γ1 = −0.22
Po
w
e
r 
o
f t
wo
−
si
de
d 
te
st
l
l
l
l
l
l
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.
0
0.
4
0.
8
γ1 = −0.36
Effect size
Po
w
e
r 
o
f t
wo
−
si
de
d 
te
st
l
l
l
l
l l
α0 = −4.06
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.
0
0.
4
0.
8
γ1 = 0
l l
l
l
l
l
l
l l
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.
0
0.
4
0.
8
γ1 = −0.11
l l
l
l
l
l
l
l l
l
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.
0
0.
4
0.
8
γ1 = −0.22
l
l
l
l
l
l
0.0 0.5 1.0 1.5 2.0 2.5 3.0
0.
0
0.
4
0.
8
γ1 = −0.36
Effect size
l
l
l
l
l l
α0 = −3.35
Figure 1: Probability of rejecting H0 : E[Y (ii)] = E[Y (i)] (no effect of text-step versus control) as a function
of the size of the effect, E[Y (ii)]−E[Y (i)]. Dotted lines indicate the nominal type I error rate of the Wald test
(0.05) and power of 80%.
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Figure 2: Probability of rejecting H0 : E[Y (ii)] = E[Y (iia)] (no effect of text + step versus text-only) as a
function of the size of the effect, E[Y (ii)]−E[Y (iia)]. Dotted lines indicate the nominal type I error rate of the
Wald test (0.05) and power of 80%.
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Figure 3: Probability of rejecting H0 :E[Y (ii)] =E[Y (iii)] (no effect of text-only versus app-only) as a function
of the size of the effect, E[Y (ii)]−E[Y (iii)]. Dotted lines indicate the nominal type I error rate of the Wald
test (0.05) and power of 80%.
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An estimate of the standard error of n1/2ψ(·)n is
σ (·)n =
[
1
n
n
∑
i=1
3
∑
t=0
{D(·)ti }2
]1/2
and the confidence intervalψ(·)n ±z1−α/2σ (·)n /n1/2, where z1−α/2 is the 1−α/2 quantile of a standard Normal
distribution, will have asymptotic coverage no smaller than 1−α .
Similar influence function-based standard error estimates can be used to describe the asymptotic covari-
ance between any two TMLEs. For example, the asymptotic covariance of n1/2(ψ(i)n ,ψ
(ii)
n )> is consistently
estimated by
Σ(i)(ii)n =
[
{σ (i)n }2 σ (i)(ii)n
σ (i)(ii)n {σ (ii)n }2
]
, where σ (i)(ii)n =
1
n
n
∑
i=1
{
3
∑
t=0
D(i)ti
3
∑
t=0
D(ii)ti
}
.
Thus, by the Delta method, an estimate of the standard error of n1/2(ψ(ii)n −ψ(i)n ) is
τn =
[
{σ (i)n }2+{σ (ii)n }2−2σ (i)(ii)n
]1/2
.
A Wald test that rejects the null hypothesis E(Y (ii)) = E(Y (i)) whenever∣∣∣∣n1/2{ψ(ii)n −ψ(i)n }τn
∣∣∣∣> z1−α/2
will have asymptotic level α .
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